MACSF

COMMUNIQUÉS West-GlobeNewswire

Doheny Eye Institute Welcomes Emma Lessieur-Contreras, MD, PhD, as Principal Investigator
05/06/2025
Dr. Lessieur-Contreras will continue her groundbreaking research on understanding the early stages of diabetic retinopathy PASADENA, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s [...]
Precision Optics Expands Facilities to Meet Growing Backlog
05/06/2025
Company signs lease to move corporate offices and engineering development to Littleton, MA Move allows for expansion of production capabilities in Gardner, MA to meet increased backlog GARDNER, Mass. and LITTLETON, Mass [...]
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
05/06/2025
FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of [...]
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
05/06/2025
New appointments of Drs. Philip C. Amrein and Alex Kentsis Validate Lead Galinpepimut-S and SLS009 Programs as Company Approaches Key Inflection Points This Year NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life [...]
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership
05/06/2025
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that Omega Laboratories Inc. of Ohio, USA (“ [...]
Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain
05/06/2025
Follow-on study (“PoC 2”) builds on initial success in pancreatic cancer pain Ethics committee authorization supports platform expansion into visceral cancer pain for proprietary ablation technology Expansion supports [...]
Tria Federal Promotes Atchut Kanthamani to President, Opens New Maryland Office
05/06/2025
ARLINGTON, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Tria Federal has promoted Atchut Kanthamani to the new position of President. In this role, he will lead Tria's business growth and technology innovation teams. [...]
TOMI Announces Appointment of David Vanston as Chief Financial Officer
05/06/2025
FREDERICK, Md., June 05, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the appointment [...]
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
05/06/2025
HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced that it has been selected for inclusion in the [...]
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
05/06/2025
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL) and transformed [...]
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
05/06/2025
Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods ® IBS Test. Gastroenterology , the premier journal in gastrointestinal science, features data [...]
DIOSynVax Presents Its Technology at the Invitation-Only Next Venture Capital Unit (VCU) Health Tech Showcase at the London Stock Exchange
05/06/2025
CAMBRIDGE, United Kingdom and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing safe, innovative, broadly protective vaccines presented its [...]
Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment
05/06/2025
HealthOST identifies vertebral height loss and bone mineral density, which are key indicators of musculoskeletal disease Osteoporosis is a common progressive bone disease among adults over 50 years of age that causes [...]
Teladoc Health to Participate in Upcoming Investor Conference
05/06/2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, [...]
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
05/06/2025
CUPERTINO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/06/2025
BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
05/06/2025
IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing [...]
Annovis to Host Webinar and Live Q&A on June 24, 2025
05/06/2025
MALVERN, Pa., June 05, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as [...]
DiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary Technology
05/06/2025
TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, [...]

Pages